NYSE Arca Biotech Index First Trust (FBT) 101.90

New Post Public Reply Private Reply Replies (0) Message Board

Sep 21, 2016 at 5:20 PM

NYSE Arca Biotech Index First Trust (FBT) 101.90 $FBT

Analysts Anticipate FBT Will Reach $119
ETFChannel.com - Fri Sep 16, 10:08AM CDT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst...
FBT: 101.90 (+1.11)

Inside the Recent Surge in Biotech ETFs
Sanghamitra Saha - Zacks Investment Research - Wed Sep 14, 1:19PM CDT
What caused biotech ETFs to tack on solid gains on September 12.
PBE: 43.30 (+0.30), SBIO: 27.16 (+0.21), PRGO: 93.69 (+0.32), RPTP: 8.99 (+0.02), GILD: 81.70 (-0.08), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), FOMX: 10.26 (+0.22), HZNP: 19.17 (+0.26), IBB: 297.53 (+1.83)

Analysts See 19% Gains Ahead For FBT
ETFChannel.com - Fri Sep 09, 6:59AM CDT
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst...
FBT: 101.90 (+1.11)

Biotech ETF Industry Outlook
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 2:39PM CDT
It has been a challenging environment for the biotech industry so far; how are these ETFs expected to perform for the rest of 2016.
PBE: 43.30 (+0.30), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), BBH: 118.17 (+0.48), IBB: 297.53 (+1.83)

Did Hillary Clinton's Tweet Cause the Sell-Off in Mylan (MYL) Stock?
Ryan McQueeney - Zacks Investment Research - Wed Aug 24, 4:29PM CDT
Shares of pharmaceutical giant Mylan Inc. (MYL) fell over 5.5% in afternoon trading Wednesday after Hillary Clinton tweeted about its price hikes of the EpiPen medication.
FBT: 101.90 (+1.11), MYL: 41.91 (+0.65), IBB: 297.53 (+1.83)

Another Endorsement for Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Tue Aug 16, 10:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), which tracks the Nasdaq Biotechnology Index, and rival biotechnology exchange traded funds, seem to have put the woes experienced earlier this year behind them and recently have been in rally...
FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83)

As Cost Panel Gets Delayed, Buy These 3 Biotech ETFs
Maher Syed - Zacks Investment Research - Thu Jun 23, 3:55PM CDT
These Biotech stocks are unique from one another, but still hold value in the way the holdings are focused. There are choices to choose from, so which one will you pick?
FBT: 101.90 (+1.11), UBIO: 31.71 (+0.64), BBH: 118.17 (+0.48)

A Catalyst for Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Mon Jun 06, 7:00AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, is up 9.2% over the past month. Performances for some rival biotech ETFs have been even better and that may be setting the stage for once beloved...
FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83)

Trying to Believe in Biotech ETFs
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Jun 03, 7:00AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs are vexing investors this year. Just when turnarounds for these funds look legitimate, they tumble again, prompting investors...
FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83)

A Fed Focused on Legacy?
editor@etftrends.com (ETF Trends) - ETF Trends - Fri Jun 03, 7:00AM CDT
Note: This article appears on the ETFtrends.com Strategist Channel By Dr. Vito Sciaraffia Federal Reserve Chairperson Paul Volker is remembered for taming the rampant inflation of the late 1970s-early 1980s. Present Chairperson Janet Yellen and her...
FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83)

Finally A Biotech ETF Bounce?
editor@etftrends.com (ETF Trends) - ETF Trends - Wed Jun 01, 7:30AM CDT
The iShares Nasdaq Biotechnology ETF (NasdaqGS: IBB), the largest biotechnology exchange traded fund, and rival biotech ETFs have been tempting, even teasing investors with signs the group may be ready to rebound this year only to let market...
BIS: 29.92 (-0.41), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83), LABD: 16.00 (-0.64)

15 Most Read ETF Articles of the Week (May 16-20)
editor@etftrends.com (ETF Trends) - ETF Trends - Fri May 20, 4:34PM CDT
Each day ETFtrends.com publishes news, strategy and commentary on ETFs in the realms of Commodities, Currency, Equities and Smart-Beta to name a few. Here’s a look at the Top 15 Most Viewed Articles of the Week on ETF Trends, May 16-20, 2016. Click...
USO: 10.40 (+0.33), SCHZ: 53.44 (+0.06), MLN: 20.76 (+0.01), HYMB: 59.25 (unch), HYD: 32.26 (+0.01), FBT: 101.90 (+1.11), GREK: 7.14 (+0.15), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83), BNO: 13.82 (+0.34), BNDX: 55.76 (+0.12), PPLT: 101.49 (+2.49), PGX: 15.19 (+0.09), SGOL: 129.81 (+1.94), FVD: 27.11 (+0.20), BSV: 80.75 (+0.02), RVNU: 27.46 (-0.07), MORT: 22.36 (+0.18), REM: 10.80 (+0.11), GLD: 127.27 (+1.83), PFF: 39.60 (+0.18), AGG: 112.03 (+0.28), IAU: 12.85 (+0.18), BND: 83.85 (+0.24)

Biotech ETFs Soar on Pfizer-Anacor Deal: SBIO, XBI in Lead
Sweta Killa - Zacks Investment Research - Tue May 17, 10:40AM CDT
Pfizer struck a deal to acquire the skin drug maker Anacor Pharmaceuticals for $5.2 billion that sent biotech ETFs higher.
AGN: 238.41 (-0.26), PBE: 43.30 (+0.30), SBIO: 27.16 (+0.21), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), PFE: 34.28 (+0.47), BBH: 118.17 (+0.48), IBB: 297.53 (+1.83), ANAC: 99.06 (-0.14)

Resisting the Temptation of Biotech ETFs
etftrends@etftrends.com (ETF Trends) - ETF Trends - Mon May 16, 7:00AM CDT
After rallying late in the first quarter and to start the current quarter, it looked liked as though biotechnology stocks and exchange traded funds were shaking the doldrums that have plagued the group dating back to last year. It appears as though...
BIS: 29.92 (-0.41), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), IBB: 297.53 (+1.83), LABD: 16.00 (-0.64), ZBIO: 19.64 (-0.32)

What Lies Ahead for Biotech ETFs?
Zacks Equity Research - Zacks Investment Research - Fri May 13, 3:48PM CDT
Should you invest in biotech ETFs now?
PBE: 43.30 (+0.30), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), BBH: 118.17 (+0.48), IBB: 297.53 (+1.83)

10 Best & Worst ETF Performers of the Day (May 11)
etftrends@etftrends.com (ETF Trends) - ETF Trends - Wed May 11, 4:04PM CDT
Welcome to the ETFtrends.com 10 Best & Worst ETF Performers of the Day for Wednesday, May 11, 2016. 10 Best ETF Performers: Sym Name Last Percent Volume UGA US Gasoline 27.57 +5.55% 93,722 SGG DJ-UBS Sugar TR Sub-Idx ETN Ipath 38.10 +5.02% 62,198...
PBE: 43.30 (+0.30), FBT: 101.90 (+1.11), XBI: 68.28 (+0.77), BNO: 13.82 (+0.34), IBB: 297.53 (+1.83), UGA: 25.94 (+0.77), EPHE: 38.23 (+0.94), XRT: 43.48 (+0.31), SBIO: 27.16 (+0.21), HEWJ: 24.81 (+0.43), GDXJ: 48.04 (+3.57), SLVP: 15.10 (+0.99), DBJP: 32.94 (+0.59), BBH: 118.17 (+0.48), FXD: 35.08 (+0.19), VIXY: 28.81 (-2.45)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

RARE Foundation Rebrands, Focus Still Strong

Unveiling the RARE Foundation's New Identity In the stock market, you ride waves of change, and let me tell you, it ain't just stocks and bonds that change names and faces. Case in point: The EveryLife Foundation for Rare Diseases has spiffed up as the RARE Foundation. New name, new logo, the whole enchilada. This isn't just a cosmetic touch-up, though. It's about...

Spot the Signs: Early Gum Disease Insights from Experts

Why Early Detection of Gum Disease Matters Let's dive right into the crux of things. Gum disease, that sneaky antagonist of oral health, starts unassumingly. You brush, you floss, but those gums might still bleed—ever noticed? Dr. Marian Burgard of Fairport Family Dental has a thing or two to say about this, enlightening us through an insightful piece by HelloNation....

Webinar Highlights Workforce Skills and AI Tools

The Shift Towards Skills-Based Talent Development The labor market's in a whirl, folks. Employers are scrambling to adapt to rapid changes, chasing after 'skills intelligence' like it's going out of style. On September 24, University of Phoenix, with its band of partners including Jobs for the Future and Skillmore™, will dig into this very topic. This upcoming webinar...

MCatalysis Secures $5M to Disrupt Fuel Cost Dynamics

Funding Fuels Innovation MCatalysis has just secured a hefty $5 million in seed funding to throw down with the big dogs in energy production. This isn't your regular backyard science project; this company is serious about changing the game with a tech-driven approach that could undercut current fuel prices. HL Energy Ventures and Oxford Science Enterprises are backing...

Hanover Unveils Skinny Veg® for GLP-1 Dieters

Seems like Hanover Foods is turning heads with their move into the ever-demanding health-conscious market. This family's stepping into the limelight with their new Skinny Veg® line, clearly targeting folks riding the GLP-1 wave. You see, it's not every day that a company that's been around the block since 1924 shakes things up like this. Simplicity is the Name of the...

IDX Expands, Enhances Team Amid 56% H1 Growth

IDX's Aggressive Global Expansion Here's a tip from a trader who’s seen cycles rise and fall: watch the movers who're playing the long game, putting down roots worldwide while making headway in the data game. IDX has clearly mapped out this trajectory as evidenced by its recent grab in the global strategic communications ring. IDX's bustling around like a squirrel...

Goodwill's ReThink Fashion: Textiles to Runway Art

Transforming Old to New on the Runway Right when you think fashion's all about the next shiny thing, here comes Goodwill of Delaware & Delaware County flipping the script. Their ReThink Fashion Show - the ECO Edit teaches us a thing or two about what giving old clothes a new life truly means. It's not just about tossing a used tee onto a catwalk but a whole rebirth...

RevSystems Joins Elite OpenAI Partner Network

RevSystems Inks Deal with OpenAI Partner Network In the latest shuffle of the AI advisory deck, RevSystems just found itself elbowing into the exclusive OpenAI Partner Network. Based out of New York, RevSystems has carved a niche by spinning tech wizardry into tangible business results. Their new status as an OpenAI Select Partner puts them on a playing field where AI...

Leidos' Autonomous Vessels Chart Bold Naval Waters

Leidos' Autonomous Leap with the U.S. Navy Well, today it's all about Leidos, an outfit that's been showing its grit in the world of maritime autonomy. Their systems aren't just tinkering around anymore—they're slicing through the waves at RIMPAC, the Rim of the Pacific, and running alongside the USS Theodore Roosevelt Carrier Strike Group. That's big news in anyone's...

The Austin Company to Showcase at ISPE Annual Event

Setting the Stage at ISPE Expo When you think of pharmaceuticals and the bustle behind closed doors, it's with companies like The Austin Company leading the charge. This October, they're strutting their stuff at the ISPE Annual Meeting and Expo. No small potatoes here—it's at the Gaylord National in Maryland. Mark those dates: October 18-21, 2026. It's a circus of...